江苏众强药业有限公司

Country

Ownership: -

Established: 2019-02-28

Employees: -

Market Cap: -

Website: www.jsforefrontpharma.com

Clinical Trials

0

Active:0

Completed:0

Trial Phases

0 Phases

Drug Approvals

1

NMPA:1

Drug Approvals

Treprostinil Injection

Product Name: 曲前列尼尔注射液

Approval Number: 国药准字H20233266

Approval Date: Mar 15, 2023

NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.